A tumor is a growth that develops when damage to a cell’s DNA causes it to copy itself excessively, forming a mass. Neuroendocrine tumors (NETs) can be either malignant, meaning they can grow ...

bioAffinity Technologies Julie Anne Overton Director of Communications jao@bioaffinitytech.com Investor Relations Dave Gentry RedChip Companies Inc. 1-800-RED-CHIP (733-2447) or 407-491-4498 BIAF ...

The NETest, a multigene liquid biopsy blood biomarker test used to diagnose neuroendocrine tumors (NETs), was found to be more accurate at predicting recurrence in patients who had undergone NET ...

The retrospective study, conducted at the University of Utah Huntsman Cancer Institute, used Biocept’s CNSide assay to detect and analyze tumor cells in the cerebrospinal fluid of 15 unique ...

Of the 3 pts with + CSF by cytology (all MBC), all were detected by TS (Table). Among 5 MBC pts with CTCs present in CSF, ER status was concordant in 2 of 5 (40%). HER2 status was concordant in 3 of 4 ...

In 2023, ASCO published a guideline on systemic therapy for tumor control in well-differentiated metastatic grade 1 to grade 3 (G1-G3) GI and pancreatic neuroendocrine tumors (GEP-NETs; Fig 1). 1 This ...

SAN ANTONIO, July 23, 2025--CyPath® Lung detected a Stage 1A neuroendocrine tumor in a patient's lung when imaging and other adjuvant tools could not.